Andreas Segerros

Andreas Segerros

Ordförande på DEXTECH MEDICAL AB
65 år
Health Technology
Consumer Services
Finance

Profil

Andreas Rutger Segerros is currently Chief Executive Officer at Sylentis SAU since 2024.
Holds Chairman positions at Oncorena AB, Dextech Medical AB, and Oncorena Holding AB. Serves as Director at Prexton Therapeutics SA. Managing Partner at Eir Ventures Danmark ApS since 2020.
Formerly Chief Executive Officer at Nicox SA from 2022 to 2024.
Served as Chief Executive Officer at Clinitrac AB. Held Chairman role at CMC Contrast AB. Worked as Independent Director at Zyla Life Sciences LLC.
Director at Egalet Ltd. in 2011.
Director at RSPR Pharma AB. Head of Business Development & Operations Planning at Ferring Pharmaceuticals A. Principal at Pharmacia, Inc. Venture Partner at Sunstone Capital A from 2012 to 2019.
Education includes an MBA from the University of Uppsala and graduate studies at the Royal Institute of Technology.

Aktiva positioner av Andreas Segerros

FöretagPositionStart
DEXTECH MEDICAL AB Ordförande -
Ordförande -
Ordförande -
Privat kapitalinvesterare 2020-07-01
Direktör/Styrelseledamot -
Verkställande Direktör 2024-05-29

Tidigare kända positioner av Andreas Segerros

FöretagPositionSlut
NICOX SA Verkställande Direktör 2024-02-28
Privat kapitalinvesterare 2019-02-01
Företagsledare/Principal -
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ -
Se detaljerna i Andreas Segerross erfarenhet

Andreas Segerross utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

34

Första gradens relationer

17

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag17

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Consumer Services

Health Technology

Consumer Services

Pharmacia, Inc.

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

  1. Börsen
  2. Insiders
  3. Andreas Segerros